111 related articles for article (PubMed ID: 7017262)
1. [Rheological and blood coagulation control during treatment of diffuse kidney diseases].
Zhavoronkov EK; Potapov VV; Potapova IV
Klin Med (Mosk); 1981 Jan; 59(1):57-63. PubMed ID: 7017262
[No Abstract] [Full Text] [Related]
2. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
Cameron JS
Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
[No Abstract] [Full Text] [Related]
3. [Comparative evaluation of the effectiveness of cyclic polychemotherapy and continuous treatment of lupus nephritis with 2 immunodepressants].
Demin AA; Sentiakova TN
Ter Arkh; 1979; 51(1):71-6. PubMed ID: 556551
[No Abstract] [Full Text] [Related]
4. [Blood coagulation in the kidney glomerulus in nephritis and nephrotic syndrome and anticoagulative therapy, with special reference to its indication and effectiveness].
Narita M; Koyama A; Tojo S
Nihon Rinsho; 1977 Jun; 35(6):2190-6. PubMed ID: 916235
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic glomerulonephritis with heparin and anticoagulants].
Kinoshita Y; Shimodori T
Nihon Rinsho; 1974 Oct; 32(10):3121-5. PubMed ID: 4475171
[No Abstract] [Full Text] [Related]
6. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
Lee GS; Woo KT; Lim CH
Clin Nephrol; 1989 May; 31(5):276. PubMed ID: 2661066
[No Abstract] [Full Text] [Related]
7. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy.
Kincaid-Smith P; Laver MC; Fairley KF
Med J Aust; 1970 Jan; 1(4):145-51. PubMed ID: 4907738
[No Abstract] [Full Text] [Related]
8. [Use of heparin in the complex treatment of lupus nephritis in children].
Kartasheva VI; Popkova GK; Torik ZhN
Vopr Revm; 1976; (1):35-41. PubMed ID: 982931
[No Abstract] [Full Text] [Related]
9. [Pathogenesis and anticoagulant treatment of autoimmune diseases of the kidneys (review of the literature)].
Shul'tsev GP; Gilunova NI; Tsalenchuk IaP
Ter Arkh; 1971 Nov; 43(11):18-23. PubMed ID: 4948318
[No Abstract] [Full Text] [Related]
10. [Anticoagulant treatment in glomerular nephropathies in children].
Schneer JH; Chipail A; Constantinescu V; Brumăr OM
Pediatria (Bucur); 1973; 22(1):69-73. PubMed ID: 4733565
[No Abstract] [Full Text] [Related]
11. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
Harnett M; Kodali BS
Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
[No Abstract] [Full Text] [Related]
12. [Prevention of clot formation and improvement of blood rheological properties during microsurgical operations. Part II. Comparative studies of small doses of acelysin and low molecular weight heparin enoxaparine (clexane)].
Vabishchevich AV; Smirnova LA; Roĭtman EV; Fedotov SA; Shibaev EIu; Svetlov VA
Anesteziol Reanimatol; 2002; (5):72-6. PubMed ID: 12611307
[No Abstract] [Full Text] [Related]
13. Coagulation assays.
Bates SM; Weitz JI
Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
[No Abstract] [Full Text] [Related]
14. [Use of curantyl in nephritis].
Rogov VA; Tareeva IE; Kutyrina IM; Nekrasova AA; Tatsievskiĭ VA
Klin Med (Mosk); 1988 Feb; 66(2):95-7. PubMed ID: 3286998
[No Abstract] [Full Text] [Related]
15. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
[TBL] [Abstract][Full Text] [Related]
16. Prevention of thrombosis during pregnancy.
Vilela VS; de Jesús NR; Levy RA
Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
[No Abstract] [Full Text] [Related]
17. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh IB; Sin'kov SV; Klevko VA
Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
[No Abstract] [Full Text] [Related]
18. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
Greaves M;
Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
[No Abstract] [Full Text] [Related]
19. [Heparin in the treatment of unstable angina. Can the decrease of the molecular size increase its effectiveness?].
Panchenko EP
Ter Arkh; 1998; 70(12):71-4. PubMed ID: 10067259
[No Abstract] [Full Text] [Related]
20. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
